|
ENLV Enlivex Therapeutics Ltd 1596812 |
| Balance Sheet |
|
Current Assets
|
28,570,000 |
|
Assets
|
31,902,000 |
|
Current Liabilities
|
2,841,000 |
|
Liabilities
|
3,340,000 |
|
Equity
|
28,562,000 |
|
Shares Out
|
21,406,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-6,307,000 |
|
Investing Cash Flow
|
4,304,000 |
| Market Analysis |
Market Cap
|
33,393,405 |
|
Price
|
1.13 |
|
BVPS
|
1.33 |
|
PB
|
0.82 |
|
EPS
|
-1.19 |
|
PS
|
0.91 |
|
FCF
|
-2,003,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ENLV documents filed with the SEC.
ENLV Filings
Clear
